Drug Profile
ZK 283197
Alternative Names: BAY86-5310; SH T04211CLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Bayer HealthCare
- Class
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Vasomotor symptoms
Most Recent Events
- 18 Feb 2014 Discontinued - Phase-II for Vasomotor symptoms in United Kingdom, Germany & Netherlands (PO)
- 31 Dec 2008 Bayer completes a phase II trial in Vasomotor symptoms in United Kingdom, Germany & Netherlands (NCT00537836)
- 31 Oct 2007 Phase-II clinical trials in Vasomotor symptoms in United Kingdom, Germany & Netherlands (PO)